MAJOR INTERCELLULAR INTERACTIONS AT THE T CELL ACTIVATION IN RENAL TRANSPLANT REJECTION

Cover Page


Cite item

Full Text

Abstract

Currently, an organ rejection is a leading cause of kidney transplants loss. Effective therapy is impossible without a clear understanding of the rejection mechanisms. In this paper, we summarize the views of domestic and foreign authors on the role of T cell activation in kidney transplant rejection.

About the authors

A. V. Vatazin

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., 129110 Moscow, Russian Federation

Email: fake@neicon.ru

д-р мед. наук, профессор, руководитель отдела трансплантологии, нефрологии и хирургической гемокоррекции МОНИКИ

Russian Federation

A. B. Zul’karnaev

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., 129110 Moscow, Russian Federation

Author for correspondence.
Email: 7059899@gmail.com

канд. мед. наук, доцент кафедры трансплантологии, нефрологии
и хирургической гемокоррекции МОНИКИ

Russian Federation

V. A. Fedulkina

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., 129110 Moscow, Russian Federation

Email: fake@neicon.ru

канд. мед. наук, мл. науч. сотр. хирургического отделения трансплантологии и диализа МОНИКИ

Russian Federation

M. Krstic

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., 129110 Moscow, Russian Federation
Family Clinic, Ltd., the Net of Family Centers; 5/2 s. 1 Sergiya Radonezhskogo ul., 105120 Moscow, Russian Federation

Email: fake@neicon.ru

канд. мед. наук, врач-уролог хирургического отделения органного донорства МОНИКИ, врач-уролог Клиники «Семейная» ООО «Сеть семейных медицинских центров»

Russian Federation

References

  1. Amirzargar A., Lessanpezeshki M., Fathi A., Amirzargar M., Khosravi F., Ansaripour B., Nikbin B. TH1/TH2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc 2005; 37(7):2985-7.
  2. Karczewski J., Karczewski M., Glyda M., Wiktorowicz K. Role of TH1/TH2 cytokines in kidney allograft rejection. Transplant Proc 2008;40(10):3390-2.
  3. Мейл Д., Бростофф Дж., Рот Д.Б., Ройтт А. Иммунология. Пер. с англ. М.: Логосфера; 2007. [Male D., Brostoff J., Roth D., Roitt I. Immunology. Moscow: Logosfera; 2007 (in Russian)].
  4. Pilat N., Sayegh M.H., Wekerle T. Costimulatory pathways in transplantation. Semin Immunol 2011;23(4):293-303.
  5. Данович Г.М., ред. Трансплантация почки. Пер. с англ. М.: ГЭОТАР-Медиа; 2013. [Danovitch G.M., editor. Renal transplantology. Moscow: GEOTAR-media; 2013 (in Russian)].
  6. Ford M.L., Larsen C.P. Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 2009;229(1):294-306.
  7. Karimi M.H., Pourfathollah A.A. CD40 and tolerance induction. Iran J Allergy Asthma Immunol 2012;11(1):1-13.
  8. Xu H., Yan J., Huang Y., Chilton P.M., Ding C., Schanie C.L., Wang L., Ildstad S.T. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood 2008;111(6):3266-75.
  9. Sugamura K., Ishii N., Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 2004;4(6):420-31.
  10. Kinnear G., Wood K.J., Marshall D., Jones N.D. Anti-OX40 prevents effector T cell accumulation and CD8+ T cell mediated skin allograft rejection. Transplantation 2010;90(12):1265-71.
  11. Burrell B.E., Lu G., Li X.C., Bishop D.K. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol 2009;182(1):379-90.
  12. Habicht A., Najafian N., Yagita H., Sayegh M.H., Clarkson M.R. New insights in CD28-independent allograft rejection. Am J Transplant 2007;7(8):1917-26.
  13. Harada H., Salama A.D., Sho M., Izawa A., Sandner S.E., Ito T., Akiba H., Yagita H., Sharpe A.H., Freeman G.J., Sayegh M.H. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003;112(2):234-43.
  14. Bullock T.N., Yagita H. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+T cell responses in the absence of CD4+ T cells. J Immunol 2005;174(2):710-7.
  15. Feau S., Garcia Z., Arens R., Yagita H., Borst J., Schoenberger S.P. The CD4⁺ T-cell help signal is transmitted from APC to CD8⁺ T-cells via CD27-CD70 interactions. Nat Commun 2012;3:948.
  16. Hirohashi T., Chase C.M., Della Pelle P., Sebastian D., Alessan drini A., Madsen J.C., Russell P.S., Colvin R.B. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 2012;12(2):313-21.
  17. Yamada A., Salama A.D., Sho M., Najafian N., Ito T., Forman J.P., Kewalramani R., Sandner S., Harada H., Clarkson M.R., Mandelbrot D.A., Sharpe A.H., Oshima H., Yagita H., Chalasani G., Lakkis F.G., Auchincloss H. Jr., Sayegh M.H. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol 2005;174(3):1357-64.
  18. Claus C., Riether C., Schürch C., Matter M.S., Hilmenyuk T., Ochsenbein A.F. CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth. Cancer Res 2012;72(14):3664-76.
  19. Hire K., Hering B., Bansal-Pakala P. Relative reductions in soluble CD30 levels post-transplant predict acute graft function in islet allograft recipients receiving three different immunosuppression protocols. Transpl Immunol 2010;23(4):209-14.
  20. Saini D., Ramachandran S., Nataraju A., Benshoff N., Liu W., Desai N., Chapman W., Mohanakumar T. Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection. Am J Transplant 2008;8(9):1798-808.
  21. Zeiser R., Nguyen V.H., Hou J.Z., Beilhack A., Zambricki E., Buess M., Contag C.H., Negrin R.S. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. Blood 2007;109(5):2225-33.
  22. Gizinski A.M., Fox D.A., Sarkar S. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets. Best Pract Res Clin Rheumatol 2010;24(4):463-77.
  23. Wang C., Lin G.H., McPherson A.J., Watts T.H. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 2009;229(1):192-215.
  24. Fan K., Wang H., Wei H., Zhou Q., Kou G., Hou S., Qian W., Dai J., Li B., Zhang Y., Zhu T., Guo Y. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance. Transplantation 2007;84(6): 746-54.
  25. Yeung M.Y., McGrath M., Najafian N. The emerging role of the TIM molecules in transplantation. Am J Transplant 2011; 11(10):2012-9.
  26. Del Rio M.L., Buhler L., Gibbons C., Tian J., Rodriguez-Barbosa J.I. PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transpl Int 2008;21(11):1015-28.
  27. Ronchetti S., Nocentini G., Petrillo M.G., Riccardi C. CD8(+) T cells: GITR matters. Sci World J 2012: 308265.
  28. McGrath M.M., Najafian N. The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 2012;3:47.
  29. Ковальчук Л.В., Ганковская Л.В., Мешкова Р.Я. Клиническая иммунология и аллергология с основами общей иммунологии. М.: ГЭОТАР-Медиа; 2011. [Koval'chuk L.V., Gankovskaya L.V., Meshkova R.Ya. Clinical immunology and allergology including the principles of general immunology. Moscow: GEOTAR-Media; 2011 (in Russian)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Vatazin A.V., Zul’karnaev A.B., Fedulkina V.A., Krstic M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies